Our results demonstrated that the intervention of probiotics significantly upregulates the expression of Claudin-1 and Claudin-3 in the ileum in NAFLD mice, thereby improving the integrity of the mucosal barrier. The gene discussed is CLDN3; the disease is metabolic dysfunction-associated steatotic liver disease.